What is the treatment for Chlamydia pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chlamydia Pneumonia

For adults with Chlamydia pneumonia, the recommended treatment is doxycycline 100 mg orally twice daily for 7 days, or a macrolide such as azithromycin 500 mg on day 1 followed by 250 mg daily for 4 days, or clarithromycin 500 mg twice daily for 7-14 days. 1

Treatment Options by Patient Population

Adults

  • First-line options:
    • Doxycycline 100 mg orally twice daily for 7 days 1, 2
    • Macrolides:
      • Azithromycin 500 mg on day 1, then 250 mg daily for 4 days 1
      • Clarithromycin 500 mg twice daily for 7-14 days 1, 3
  • Alternative options:
    • Respiratory fluoroquinolones (for patients with comorbidities):
      • Levofloxacin 500 mg daily or 750 mg daily for 5-7 days 1, 4
      • Moxifloxacin 400 mg daily for 7-14 days 1

Children

  • Children who weigh <45 kg:
    • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into 4 doses daily for 14 days 1
  • Children who weigh >45 kg but are <8 years old:
    • Azithromycin 1 g orally in a single dose 1
  • Children ≥8 years old:
    • Azithromycin 1 g orally in a single dose, OR
    • Doxycycline 100 mg orally twice daily for 7 days 1

Infants with C. trachomatis pneumonia

  • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into 4 doses daily for 14 days 1
  • Follow-up is recommended as treatment effectiveness is approximately 80% and a second course may be required 1

Clinical Considerations

Diagnostic Approach

  • Diagnosis of Chlamydia pneumonia can be challenging as clinical presentation may mimic other atypical pneumonias 5, 6
  • Common symptoms include:
    • Gradual onset of symptoms
    • Persistent cough (often non-productive)
    • Low-grade fever
    • In infants: staccato cough with tachypnea 1
  • Laboratory findings may include peripheral eosinophilia in infants 1

Treatment Duration

  • Treatment duration should generally not exceed 8 days in responding patients 1
  • For C. pneumoniae specifically, 7-14 days of therapy is typically recommended 1
  • For infants with C. trachomatis pneumonia, 14 days of therapy is recommended 1

Special Considerations

  • For patients with comorbidities (chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancies; immunosuppression), consider respiratory fluoroquinolones or a β-lactam plus a macrolide 1
  • Azithromycin has FDA approval for community-acquired pneumonia due to Chlamydia pneumoniae in patients appropriate for oral therapy 7
  • Levofloxacin is indicated for community-acquired pneumonia due to Chlamydophila pneumoniae 4

Follow-up Recommendations

  • Follow-up is particularly important for infants with chlamydial pneumonia to ensure resolution 1
  • Some infants with chlamydial pneumonia may have abnormal pulmonary function tests later in childhood 1
  • Sexual abstinence for 7 days after completing treatment is recommended for sexually transmitted C. trachomatis infections 8

Common Pitfalls and Caveats

  • Erythromycin has approximately 80% effectiveness in treating chlamydial pneumonia; a second course may be required if symptoms persist 1
  • Azithromycin should not be used in patients with known QT interval prolongation, history of torsades de pointes, or uncompensated heart failure due to risk of cardiac arrhythmias 7
  • Fluoroquinolones should be used cautiously in patients with risk factors for QT prolongation 4
  • Doxycycline should be avoided in pregnant women and children under 8 years of age due to risk of dental staining 1
  • Macrolides are preferred for pregnant women with chlamydial infections 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The chlamydial pneumonias.

Drugs of today (Barcelona, Spain : 1998), 1998

Research

[Clinical manifestations of Chlamydia pneumoniae infections].

La Revue de medecine interne, 1996

Research

Chlamydophila pneumoniae.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009

Guideline

Duration of Sexual Abstinence After Treatment for STIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.